Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy.

Clin Transl Oncol · 2022 · PMC9243719 · PMID 35752749

Europe PMC DOI

hedged sentence

0.1300

closest p · 2.6× alpha

0.1300

boldest claim

The sentences

did not reach statistical significanceP = 0.13not close (p > 0.1)

The data included in TCGA showed that HNSCC patients with elevated levels of FNDC4 had lower overall survival, although the differences did not reach statistical significance ( P = 0.13).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.